- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05879211
Goal Concordant Care Learning Laboratory
August 5, 2026 updated by: Duke University
Palliative Care Learning Laboratory
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.
Study Overview
Status
Enrolling by invitation
Conditions
Intervention / Treatment
Detailed Description
The goal-concordant care lab will develop and test strategies to optimize communication in advanced serious illness.
The lab will test a variety of interventions, including triggered conversations and feedback to healthcare providers.
Study Type
Interventional
Enrollment (Estimated)
5000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Duke Health patient
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Usual care
|
|
|
Experimental: Intervention
Feedback to provider regarding frequency and quality of communication
|
Providers will receive detailed feedback about the timing, quality, and frequency of their goals of care communication with patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Frequency of goals of care communication
Time Frame: 2 years
|
Frequency of goals of care conversations in the last 6 months of life
|
2 years
|
|
Timing of goals of care communication
Time Frame: 6 months
|
Proximity of goals of care communication to death
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 12, 2023
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
May 14, 2023
First Submitted That Met QC Criteria
May 26, 2023
First Posted (Actual)
May 30, 2023
Study Record Updates
Last Update Posted (Actual)
August 6, 2026
Last Update Submitted That Met QC Criteria
August 5, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Cardiovascular Diseases
- Mental Disorders
- Pathologic Processes
- Heart Diseases
- Chronic Disease
- Disease Attributes
- Respiratory Tract Diseases
- Neurocognitive Disorders
- Lung Diseases
- Lung Diseases, Obstructive
- Pathological Conditions, Signs and Symptoms
- Neoplasms
- Heart Failure
- Pulmonary Disease, Chronic Obstructive
- Dementia
Other Study ID Numbers
- Pro00106230
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.